CPHI China 2025 opened with great fanfare at Shanghai New International Expo Centre on June 24. As a globally renowned pharmaceutical manufacturer and distributor, Sunrise Group unveiled its products at Booth W2A32, spanning pharmaceuticals, agrochemicals, and veterinary medicine. Attendees explored the company's integrated supply chain solutions, a testament to its technical prowess and global service expertise.

During the exhibition, Sunrise Group garnered significant industry attention with its multi-dimensional product matrix, attracting numerous domestic and international clients for business discussions. We specialize in the R&D and supply of pharmaceutical, pesticide, and veterinary drug APIs and intermediates. Leveraging stable product quality and cross-domain application value, we have established an efficient industry platform for communication and collaboration. The strong market recognition further strengthens our commitment to deepening global resource integration and innovating high-quality pharmaceutical solutions.

Sunrise Group maintains an unwavering commitment to its customer-first, value-focused philosophy. Through strategic global expansion, we continue to forge cross-border partnerships while optimizing our worldwide operational footprint. Moving forward, we will integrate premium resources across the pharmaceutical value chain through an open and inclusive approach, fostering collaboration to establish new benchmarks for industry excellence.

About us